Gastroprotection during long-term dual antiplatelet therapy:to give or not to give?

被引:0
|
作者
Francesco Sbrana [1 ]
Andrea Ripoli [1 ]
Beatrice Dal Pino [1 ]
机构
[1] Fondazione Toscana “Gabrielel Monasterio”,Via Giuseppe Moruzzi 1
关键词
D O I
暂无
中图分类号
R969 [临床药理学];
学科分类号
100602 ; 100706 ;
摘要
Dear Editor,We read with interest Kim J, et al. titled "Potentially inappropriate prescribing of cardiovascular system and antiplatelet/anticoagulant drugs among elderly patients: a Korean population-based national study"[1] highlighting that the more frequent potentially inappropriate prescribing was, in elderly subjects, the non-steroidal anti-inflammatory drug with concurrent antiplatelet agent without protonpump inhibitor prophylaxis(PPI).
引用
收藏
页码:973 / 974
页数:2
相关论文
共 50 条
  • [41] Biomaterial modification of urinary catheters with antimicrobials to give long-term broadspectrum antibiofilm activity
    Fisher, Leanne E.
    Hook, Andrew L.
    Ashraf, Waheed
    Yousef, Anfal
    Barrett, David A.
    Scurr, David J.
    Chen, Xinyong
    Smith, Emily F.
    Fay, Michael
    Parmenter, Christopher D. J.
    Parkinson, Richard
    Bayston, Roger
    [J]. JOURNAL OF CONTROLLED RELEASE, 2015, 202 : 57 - 64
  • [42] LONG-TERM ANTIPLATELET THERAPY FOR THE PREVENTION OF VASCULAR-DISEASE
    MACMAHON, S
    SHARPE, N
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1991, 154 (07) : 477 - 480
  • [43] Risk of Long-Term Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Octogenarians
    Matsumi, Junya
    Takeshita, Satoshi
    Shishido, Koki
    Sugitatsu, Kazuya
    Mizuno, Shingo
    Suenaga, Hidetaka
    Tanaka, Yutaka
    Takahashi, Saeko
    Saito, Shigeru
    [J]. JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2013, 26 (02) : 114 - 122
  • [44] Long-term Impact of Baseline Anemia and Dual Antiplatelet Therapy Duration After Percutaneous Coronary Intervention
    Kim, Huntae
    Park, Jong-Il
    Kim, Byung-Jun
    Lee, Jung-Hee
    Kim, Ung
    Park, Jong-Seon
    [J]. CIRCULATION, 2020, 142
  • [45] Long-Term Duration of Dual Antiplatelet Therapy Patient Complexity Is More Important Than Lesion Complexity
    Colombo, Antonio
    Giannini, Francesco
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (18) : 2224 - 2225
  • [46] Smoking influences the effectiveness of dual antiplatelet therapy on long-term outcomes following percutaneous coronary intervention
    Kiran, YA
    Steinhubl, SR
    Hsu, AP
    Topol, EJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 36B - 36B
  • [47] Close encounters with errors of the second kind: evaluating risks and benefits of long-term dual antiplatelet therapy
    Yeh, Robert W.
    Cohen, David J.
    Mauri, Laura
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 (20) : 1216 - 1218
  • [48] Premature Discontinuation of Dual Antiplatelet Therapy After Coronary Stenting in Veterans: Characteristics and Long-Term Outcomes
    Kinlay, Scott
    Quach, Lien
    Cormack, Jean
    Morgenstern, Natalie
    Hou, Ying
    Young, Melissa
    Sherrod, Rebecca
    Cho, Kelly
    Faxon, David P.
    Ramadan, Ronnie
    Gaziano, Michael
    Gagnon, David
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (09):
  • [50] PUVA in early mycosis fungoides may give long-term remission and delay extracutaneous spread
    Roupe, G
    Sandstrom, MH
    Kjellstrom, C
    [J]. ACTA DERMATO-VENEREOLOGICA, 1996, 76 (06) : 475 - 478